Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03134768
Other study ID # CAE.1C.D.10
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2, 2016
Est. completion date October 12, 2017

Study information

Verified date April 2020
Source Danone Asia Pacific Holdings Pte, Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of the study is to understand the immediate effect of birth on immunological parameters in vaginally born cord blood.


Description:

The main purpose of the study is to understand the immediate effect of birth on immunological parameters in vaginally born cord blood and also whether mode and duration of delivery has an influence on immune parameters in cord blood.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date October 12, 2017
Est. primary completion date November 16, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Pregnant mothers undergoing normal vaginal delivery

Exclusion Criteria:

- Use of non-steroidal anti-inflammatory drugs (NSAIDs) 2 weeks prior to birth

- Antenatal antibiotics treatment (2 weeks prior to birth)

- Diabetes mellitus requiring insulin treatment during pregnancy

- Uncontrollable Hyperthyroidism during pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
This is not an interventional study
This is an observational study

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Danone Asia Pacific Holdings Pte, Ltd.

Outcome

Type Measure Description Time frame Safety issue
Primary Cytokines Profile in Cord Blood Plasma Following cytokines will be part of the profile: IL-6, IL-1, IL-2, IL-4, IL-5, IL-7, IL-8, IL-10, IL12p70, IL-13, IL-17, G-CSF, GM-CSF, IFNg, MCP-1(MCAF), MIP-1b, TNFa 1 year
Primary Cord Blood Immunoglobulin Levels Immunoglobulin levels will be measured in cord blood plasma 1 year
Primary Allergen Stimulated Cytokine Expression in the Supernatants of Cord Blood Mononuclear Cells (CBMC) Cellular response to allergen stimulation will be measured in supernatants of cultured cord blood mononuclear cells. 1 year
See also
  Status Clinical Trial Phase
Completed NCT03796949 - Threatened Preterm Birth and Time of Subsequent Delivery -a Prediction Model
Completed NCT04354792 - Asymptomatic COVID-19 Infection Among Healthcare Workers
Terminated NCT01210066 - Pain, Opioids and Pro-Inflammatory Immune Responses Phase 1
Recruiting NCT03928431 - Restoration of Microbiota in Neonates N/A
Completed NCT04768621 - Health Consequences of Wintering in the French Southern and Antarctic Territories N/A